IRIS
EMDIN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 63.406
EU - Europa 36.194
AS - Asia 27.970
SA - Sud America 7.972
AF - Africa 654
Continente sconosciuto - Info sul continente non disponibili 156
OC - Oceania 58
Totale 136.410
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 60.353
SG - Singapore 11.678
RU - Federazione Russa 10.900
GB - Regno Unito 8.141
CN - Cina 6.968
BR - Brasile 6.500
IT - Italia 5.208
VN - Vietnam 3.998
DE - Germania 2.784
UA - Ucraina 2.599
CA - Canada 2.357
HK - Hong Kong 1.982
DK - Danimarca 1.583
SE - Svezia 1.021
IE - Irlanda 728
FR - Francia 699
FI - Finlandia 661
PL - Polonia 636
AR - Argentina 549
IN - India 544
MX - Messico 520
IL - Israele 392
BD - Bangladesh 381
TR - Turchia 357
NL - Olanda 348
ID - Indonesia 338
EC - Ecuador 301
ZA - Sudafrica 278
JP - Giappone 265
ES - Italia 251
IQ - Iraq 192
AT - Austria 181
PK - Pakistan 163
EU - Europa 149
CO - Colombia 145
LT - Lituania 108
PY - Paraguay 107
VE - Venezuela 104
UZ - Uzbekistan 99
MA - Marocco 95
AE - Emirati Arabi Uniti 94
CL - Cile 86
PE - Perù 74
SA - Arabia Saudita 63
KR - Corea 60
UY - Uruguay 59
IR - Iran 58
KE - Kenya 55
EG - Egitto 53
BE - Belgio 46
SK - Slovacchia (Repubblica Slovacca) 46
TN - Tunisia 44
CH - Svizzera 35
DZ - Algeria 35
JO - Giordania 35
BO - Bolivia 33
AZ - Azerbaigian 31
RO - Romania 31
AU - Australia 29
DO - Repubblica Dominicana 29
CZ - Repubblica Ceca 28
NP - Nepal 27
HN - Honduras 24
CR - Costa Rica 23
KZ - Kazakistan 22
JM - Giamaica 20
MY - Malesia 20
PH - Filippine 20
PT - Portogallo 19
AL - Albania 18
AM - Armenia 18
NZ - Nuova Zelanda 18
TW - Taiwan 17
CI - Costa d'Avorio 16
ET - Etiopia 15
OM - Oman 15
TH - Thailandia 15
TT - Trinidad e Tobago 15
KG - Kirghizistan 14
KW - Kuwait 14
NI - Nicaragua 14
SN - Senegal 14
GE - Georgia 13
LB - Libano 13
PA - Panama 13
GT - Guatemala 11
PS - Palestinian Territory 11
BG - Bulgaria 10
BH - Bahrain 10
GR - Grecia 10
GY - Guiana 10
RS - Serbia 10
BB - Barbados 9
BY - Bielorussia 9
HU - Ungheria 9
MD - Moldavia 9
NG - Nigeria 9
LV - Lettonia 8
MC - Monaco 8
GD - Grenada 7
Totale 136.244
Salva come PNG Salva come JPEG
Città #
Dallas 13.815
Singapore 6.189
Southend 5.518
Beijing 3.412
Ashburn 3.215
Woodbridge 2.868
Chandler 2.554
Ann Arbor 2.547
Houston 2.334
Moscow 1.993
Fairfield 1.913
San Mateo 1.857
Los Angeles 1.816
Chicago 1.780
Hong Kong 1.750
Falls Church 1.553
Dearborn 1.327
Seattle 1.324
Jacksonville 1.195
Wilmington 1.148
Cambridge 1.147
Ho Chi Minh City 1.106
Ottawa 943
The Dalles 818
Hefei 803
Salt Lake City 752
Boardman 732
Dublin 710
New York 692
São Paulo 687
Stevenage 685
Buffalo 682
Portsmouth 682
Dong Ket 641
Pisa 622
Warsaw 589
Hanoi 585
Lawrence 525
Santa Clara 449
Beauharnois 444
Brooklyn 429
Tampa 421
Munich 411
Montréal 406
Milan 386
Tel Aviv 351
Elk Grove Village 344
Rome 332
London 314
Montreal 259
Tokyo 237
Rio de Janeiro 222
Denver 213
San Diego 213
Poplar 210
Stockholm 209
Frankfurt am Main 206
Florence 205
Chennai 200
Orem 197
Johannesburg 193
Istanbul 189
Phoenix 186
Mexico City 179
Atlanta 176
Nuremberg 167
Sterling 163
Redwood City 160
Old Bridge 158
Lancaster 153
Boston 152
Belo Horizonte 133
Helsinki 132
Brasília 129
Toronto 127
Miami 126
Haiphong 124
Amsterdam 121
San Francisco 118
Guangzhou 116
Lappeenranta 115
Central District 114
Turku 113
Curitiba 109
Guayaquil 107
Manchester 103
Porto Alegre 99
Ankara 98
Dulles 98
Council Bluffs 97
Da Nang 96
Tashkent 93
Biên Hòa 91
Fremont 91
Campinas 90
Washington 89
Kansas City 86
Norwalk 85
Querétaro 84
Quito 84
Totale 85.111
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.793
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.598
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.510
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 1.279
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 829
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 661
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 551
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 451
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 444
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 425
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 413
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 406
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 357
Impaired HDL Cholesterol Function and High Interleukin-1ß Levels Hold Prognostic Value after ST-elevation Myocardial Infarctio 348
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 344
Cartella clinica automatizzata per il reparto di cardiologia 334
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 332
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 332
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 330
Trastuzumab cardiotoxicity and drug cardioprotection in healthy and cardiac dysfunction mouse models 326
Intelligent data retrieval system as a decision support in cardiology in an Intranet environment 315
An Open System for Managing Long Term ECG Recordings 313
La neuropatia diabetica 313
Building medical knowledge from real world registries: The case of heart failure 313
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 313
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 311
A simple echocardiographic score to rule out cardiac amyloidosis 306
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 304
Central sleep apnea and cardiovascular disease state-of-the-art 299
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 298
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 295
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 293
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 292
Treating chemoreflex in heart failure: modulation or demolition? 292
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 290
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 289
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 288
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 288
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 287
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 284
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 281
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 280
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 280
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 279
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 279
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 279
Preliminary usability assessment for a novel robotic interface for remote Doppler-echocardiography 279
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 278
Adrenergic activation in heart failure: blockade or rebalance? 276
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 275
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 274
Prognostic Impact of QRS Axis Deviation in Patients Treated with Cardiac Resynchronization Therapy 271
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 269
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 268
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 268
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 267
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 267
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 264
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 262
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 262
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 262
Prediction of the chemoreflex gain by common clinical variables in heart failure 261
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 260
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 260
A simple echocardiographic score to rule out cardiac amyloidosis 258
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 258
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 258
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 257
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 255
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 254
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 254
[Central apneas and cardiovascular diseases] 253
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 253
Diagnostic accuracy and prognostic relevance of the measurement of the cardiac natriuretic peptides: a review 253
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 253
Effects of smoking in patients treated with cardiac resynchronization therapy 253
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. 252
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 250
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 250
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 250
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 248
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 248
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 247
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 246
Chronotropic response to vasodilator-stress in patients submitted to myocardial perfusion imaging: impact on the accuracy in detecting coronary stenosis 245
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 245
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 244
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 244
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 243
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 242
ST segment/heart rate hysteresis improves the diagnostic accuracy of ECG stress test for coronary artery disease in patients with left ventricular hypertrophy 242
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 242
Development of an Electronic Medical Record for Patient Care in Cardiology 242
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 241
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 238
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 237
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 237
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 237
Nuovi strumenti di management per la gestione integrata dei percorsi assistenziali dei pazienti cronici 237
Medical record System for Cardiology and Cardiac Surgery 236
Totale 34.449
Salva come PNG Salva come JPEG
Categoria #
all - tutte 725.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 725.773
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.529 0 0 0 0 0 1.601 1.075 605 923 664 1.040 1.621
2021/20228.856 788 1.557 404 889 180 250 922 1.669 502 941 138 616
2022/20235.887 547 376 172 845 776 931 52 486 1.037 118 330 217
2023/20244.142 345 129 800 249 173 445 352 194 212 202 162 879
2024/202534.921 265 325 1.822 648 1.291 1.781 4.145 7.450 2.628 3.835 6.773 3.958
2025/202650.351 4.297 13.612 10.203 10.763 8.532 2.944 0 0 0 0 0 0
Totale 137.317